Completed NA INTERVENTIONAL 2-arm NCT03986099

Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART (CBART)

Community Based Virus Load Differentiated Care in Rural Africa

Sponsor: Biomedical Research and Training Institute, Zimbabwe

Updated 5 times since 2019 Last updated: Nov 16, 2020 Started: Feb 1, 2018 Primary completion: Jun 15, 2020 Completion: Nov 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03986099, this NA trial focuses on ART and HIV I Infection and remains completed. Sponsored by Biomedical Research and Training Institute, Zimbabwe, it has been updated 5 times since 2018, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jul 2019 — Dec 2020 [monthly]

Recruiting NA

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biomedical Research and Training Institute, Zimbabwe
Gilead Sciences

Data source: Biomedical Research and Training Institute, Zimbabwe

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karoi, Zimbabwe